Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intermittent vs Daily Iron in Pregnant Women
NCT05278793Phase 4Unknown
- Sponsor
- Martini Ziekenhuis
- Start
- Jan 2022
- Primary completion
- Dec 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ferrous fumarate in iron deficiency anemia (IDA) (2 arms), sponsored by Martini Ziekenhuis. Primary endpoint: Haemoglobin level at 6 weeks. Status: unknown.
02
Drugs
ferrous fumarate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT05278793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05278793.